132 related articles for article (PubMed ID: 9636427)
1. CD95L confers immune priviledge to liver grafts which are spontaneously accepted.
Fändrich F; Lin X; Zhu X; Klöppel G; Parwaresch R; Kremer B
Transplant Proc; 1998 Jun; 30(4):1057-8. PubMed ID: 9636427
[No Abstract] [Full Text] [Related]
2. Investigations of the immunoprotective role of the liver after allogeneic orthotopic combined liver-small-bowel transplantation in the rat.
Gassel HJ; Timmermann W; Meyer D; Gassel AM; Thiede A
Transplant Proc; 1997; 29(1-2):693-4. PubMed ID: 9123484
[No Abstract] [Full Text] [Related]
3. The role of Fas/FasL apoptotic pathway in the development of chronic rejection.
Subbotin V; Sun H; Aitouche A; Salam A; Valdivia LA; Fung JJ; Starzl TE; Rao AS
Transplant Proc; 1999; 31(1-2):1397-8. PubMed ID: 10083618
[No Abstract] [Full Text] [Related]
4. Apoptosis of crypt cells and lymphocytes in gut-associated lymphoid tissues during small intestinal graft rejection in rats.
Park YJ; Fujisaki S; Kimizuka K; Shugito K; Tomita R; Fukuzawa M; Matsumoto K
Transplant Proc; 2004 Mar; 36(2):353-5. PubMed ID: 15050157
[TBL] [Abstract][Full Text] [Related]
5. Thymic and liver graft expression of CD95-L tolerizes allogeneic orthotopic liver grafts.
Fändrich F; Lin X; Huang DS; Zhu X; Parwaresch R; Kremer B; Henne-Bruns D
Transplant Proc; 1999; 31(1-2):438-9. PubMed ID: 10083178
[No Abstract] [Full Text] [Related]
6. Immunohistochemical analysis in the extracellular matrix during acute rejection of small bowel grafts in rats.
Fujisaki S; Kimizuka K; Park E; Tomita R; Fukuzawa M; Matsumoto K
Transplant Proc; 2000 Sep; 32(6):1316-7. PubMed ID: 10995964
[No Abstract] [Full Text] [Related]
7. Orthotopic liver transplantation can protect small bowel free grafts from rejection.
Lee SK; Perez-Atayde A; Vacanti JP; Lund DP
Transplant Proc; 1994 Aug; 26(4):2300-1. PubMed ID: 8066757
[No Abstract] [Full Text] [Related]
8. GvHD after small bowel transplantation: the role of caspases, FAS-L, and galectin-1.
Fändrich F; Zepernick-Kalinski C; Lin X
Transplant Proc; 1998 Sep; 30(6):2594-5. PubMed ID: 9745506
[No Abstract] [Full Text] [Related]
9. Donor-derived alloantigen-presenting cells persist in the liver allograft during tolerance induction.
Meyer D; Löffeler S; Otto C; Czub S; Gassel HJ; Timmermann W; Thiede A; Ulrichs K
Transpl Int; 2000; 13(1):12-20. PubMed ID: 10743684
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis and the expression of Fas and Fas-ligand antigen after orthotopic liver transplantation.
Tannapfel A; Kohlhaw K; Schwarz R; Wenzke M; Köckerling F; Ebelt J; Hauss J; Wittekind C
Transplant Proc; 1998 Aug; 30(5):2358-9. PubMed ID: 9723503
[No Abstract] [Full Text] [Related]
11. Acute rejection of rat renal allografts is influenced by the presence of a native kidney.
Grau V; Herbst B; Steiniger B
Transplant Proc; 1997 May; 29(3):1723. PubMed ID: 9142247
[No Abstract] [Full Text] [Related]
12. Use of CD14 and lipopolysaccharide binding protein mRNA expression as markers for acute rejection in rat small bowel transplantation.
Cicalese L; Freeswick PD; Watkins SC; Kelly E; Zeidan M; Rao AS; Stanko RT
Transplant Proc; 1996 Oct; 28(5):2470. PubMed ID: 8907907
[No Abstract] [Full Text] [Related]
13. Apoptosis in combined liver/small bowel transplantation.
Meyer D; Baumgardt S; Löffeler S; Gassel HJ; Czub S; Ulrichs K; Thiede A
Transplant Proc; 1998 Sep; 30(6):2588. PubMed ID: 9745502
[No Abstract] [Full Text] [Related]
14. Expression of Bcl-2/Bax mRNA in grafted liver during acute rejection after rat liver transplantation.
Yamamoto H; Ohdan H; Shintaku S; Miyata Y; Marubayashi S; Asahara T; Ito H; Dohi K
Transplant Proc; 1998 Nov; 30(7):2950-1. PubMed ID: 9838300
[No Abstract] [Full Text] [Related]
15. Rejection rate of a small bowel allografts is reduced by liver transplantation.
Meyer D; Gassel HJ; Timmermann W; Otto C; Ulrichs K; Thiede A
Transplant Proc; 2000 Sep; 32(6):1287. PubMed ID: 10995950
[No Abstract] [Full Text] [Related]
16. Medial cell apoptosis precedes the development of intimal hyperplasia after transient allogeneic exposure in a rat aortic allograft model of chronic rejection.
Hare GM; Lee TD; Jordan JL; Hirsch GM
Transplant Proc; 1999; 31(1-2):1384-5. PubMed ID: 10083612
[No Abstract] [Full Text] [Related]
17. Apoptosis of alloreactive T cells in liver allografts during tolerance induction.
Meyer D; Thorwarth M; Otto C; Gassel HJ; Timmermann W; Ulrichs K; Thiede A
Transplant Proc; 1999; 31(1-2):474. PubMed ID: 10083196
[No Abstract] [Full Text] [Related]
18. Donor cell population in the liver allograft reflects the recipient immune status.
Meyer D; Löffeler S; Otto C; Gassel HJ; Timmermann W; Ulrichs K; Thiede A
Transplant Proc; 1999; 31(1-2):437. PubMed ID: 10083177
[No Abstract] [Full Text] [Related]
19. Mechanisms of rejection of nonvascularized grafts: the role of perforin and Fas.
Selvaggi G; Ricordi C; Podack E; Inverardi L
Transplant Proc; 1997 Jun; 29(4):2075-6. PubMed ID: 9193534
[No Abstract] [Full Text] [Related]
20. Die and let live: eliminating dangerous lymphocytes.
Abbas AK
Cell; 1996 Mar; 84(5):655-7. PubMed ID: 8625402
[No Abstract] [Full Text] [Related]
[Next] [New Search]
